HEADER HYDROLASE/HYDROLASE INHIBITOR 19-OCT-04 1W9V TITLE SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN TITLE 2 AGAINST ASPERGILLUS FUMIGATUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.1.14; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ARGIFIN; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS FUMIGATUS; SOURCE 3 ORGANISM_TAXID: 746128; SOURCE 4 ATCC: 13073; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX6P; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: GLIOCLADIUM; SOURCE 13 ORGANISM_TAXID: 62887 KEYWDS CHITINASE, ARGIFIN, CHITINASE INHIBITORS, CYCLOPENTAPEPTIDE KEYWDS 2 INHIBITORS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON,D.J.ADAMS, AUTHOR 2 K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN REVDAT 6 13-DEC-23 1W9V 1 REMARK LINK REVDAT 5 08-FEB-17 1W9V 1 SOURCE REVDAT 4 13-JUL-11 1W9V 1 VERSN REVDAT 3 24-FEB-09 1W9V 1 VERSN REVDAT 2 29-JUN-05 1W9V 1 JRNL REVDAT 1 10-JAN-05 1W9V 0 JRNL AUTH F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON, JRNL AUTH 2 D.J.ADAMS,K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN JRNL TITL SPECIFICITY AND AFFINITY OF NATURAL PRODUCT JRNL TITL 2 CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, JRNL TITL 3 HUMAN AND BACTERIAL CHITINASES JRNL REF CHEM.BIOL. V. 12 65 2005 JRNL REFN ISSN 1074-5521 JRNL PMID 15664516 JRNL DOI 10.1016/J.CHEMBIOL.2004.10.013 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2206999.940 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 88301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4436 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 11867 REMARK 3 BIN R VALUE (WORKING SET) : 0.3030 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 624 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6237 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 1080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : 0.70000 REMARK 3 B33 (A**2) : -1.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.440 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.980 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.970 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 51.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ARGIFIN.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : ARGIFIN.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W9V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1290021357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 113.0 REMARK 200 PH : 9.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979488 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEACH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 88304 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1D2K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M LI2SO4 0.1 M TRIS PH 9.5, PH REMARK 280 9.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.89150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.94575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 74.83725 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ARGIFIN IS OLIGOPEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ARGIFIN REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 2 REMARK 465 PHE A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 SER A 6 REMARK 465 THR A 7 REMARK 465 ILE A 8 REMARK 465 VAL A 9 REMARK 465 LYS A 10 REMARK 465 VAL A 11 REMARK 465 ALA A 12 REMARK 465 LEU A 13 REMARK 465 LEU A 14 REMARK 465 LEU A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 LEU A 18 REMARK 465 CYS A 19 REMARK 465 VAL A 20 REMARK 465 ASP A 21 REMARK 465 ALA A 22 REMARK 465 ALA A 23 REMARK 465 VAL A 24 REMARK 465 MET A 25 REMARK 465 TRP A 26 REMARK 465 ASN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 THR A 30 REMARK 465 SER A 31 REMARK 465 SER A 32 REMARK 465 THR A 33 REMARK 465 ASP A 34 REMARK 465 LEU A 35 REMARK 465 GLU A 36 REMARK 465 ALA A 37 REMARK 465 ARG A 38 REMARK 465 MET B 1 REMARK 465 ARG B 2 REMARK 465 PHE B 3 REMARK 465 ALA B 4 REMARK 465 THR B 5 REMARK 465 SER B 6 REMARK 465 THR B 7 REMARK 465 ILE B 8 REMARK 465 VAL B 9 REMARK 465 LYS B 10 REMARK 465 VAL B 11 REMARK 465 ALA B 12 REMARK 465 LEU B 13 REMARK 465 LEU B 14 REMARK 465 LEU B 15 REMARK 465 SER B 16 REMARK 465 SER B 17 REMARK 465 LEU B 18 REMARK 465 CYS B 19 REMARK 465 VAL B 20 REMARK 465 ASP B 21 REMARK 465 ALA B 22 REMARK 465 ALA B 23 REMARK 465 VAL B 24 REMARK 465 MET B 25 REMARK 465 TRP B 26 REMARK 465 ASN B 27 REMARK 465 ARG B 28 REMARK 465 ASP B 29 REMARK 465 THR B 30 REMARK 465 SER B 31 REMARK 465 SER B 32 REMARK 465 THR B 33 REMARK 465 ASP B 34 REMARK 465 LEU B 35 REMARK 465 GLU B 36 REMARK 465 ALA B 37 REMARK 465 ARG B 38 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR B 433 CA C O CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 55 -111.53 -87.96 REMARK 500 TYR A 112 -127.76 -122.90 REMARK 500 ALA A 259 25.91 -150.94 REMARK 500 ASN A 267 63.23 -155.62 REMARK 500 GLN A 318 -166.65 -78.65 REMARK 500 TYR B 55 -113.26 -91.61 REMARK 500 TYR B 112 -132.31 -123.10 REMARK 500 ALA B 259 23.14 -153.13 REMARK 500 ASN B 267 64.84 -155.10 REMARK 500 GLN B 318 -153.19 -74.77 REMARK 500 SER B 413 113.65 -165.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2035 DISTANCE = 6.86 ANGSTROMS REMARK 525 HOH A2069 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH A2194 DISTANCE = 6.41 ANGSTROMS REMARK 525 HOH B2059 DISTANCE = 6.09 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 9-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 10-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1438 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1439 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1437 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1438 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1439 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ARGIFIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF ARGIFIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1W9P RELATED DB: PDB REMARK 900 SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE REMARK 900 INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, HUMAN AND BACTERIAL REMARK 900 CHITINASEFRA REMARK 900 RELATED ID: 1W9U RELATED DB: PDB REMARK 900 SPECIFICITY AND AFFNITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE REMARK 900 INHIBITOR ARAGADIN AGAINST ASPERGILLUS FUMIGATUS CHITINASE DBREF 1W9V A 1 433 UNP Q873X9 Q873X9 1 433 DBREF 1W9V B 1 433 UNP Q873X9 Q873X9 1 433 DBREF 1W9V C 1434 1438 PDB 1W9V 1W9V 1434 1438 DBREF 1W9V D 1434 1438 PDB 1W9V 1W9V 1434 1438 SEQRES 1 A 433 MET ARG PHE ALA THR SER THR ILE VAL LYS VAL ALA LEU SEQRES 2 A 433 LEU LEU SER SER LEU CYS VAL ASP ALA ALA VAL MET TRP SEQRES 3 A 433 ASN ARG ASP THR SER SER THR ASP LEU GLU ALA ARG ALA SEQRES 4 A 433 SER SER GLY TYR ARG SER VAL VAL TYR PHE VAL ASN TRP SEQRES 5 A 433 ALA ILE TYR GLY ARG ASN HIS ASN PRO GLN ASP LEU PRO SEQRES 6 A 433 VAL GLU ARG LEU THR HIS VAL LEU TYR ALA PHE ALA ASN SEQRES 7 A 433 VAL ARG PRO GLU THR GLY GLU VAL TYR MET THR ASP SER SEQRES 8 A 433 TRP ALA ASP ILE GLU LYS HIS TYR PRO GLY ASP SER TRP SEQRES 9 A 433 SER ASP THR GLY ASN ASN VAL TYR GLY CYS ILE LYS GLN SEQRES 10 A 433 LEU TYR LEU LEU LYS LYS GLN ASN ARG ASN LEU LYS VAL SEQRES 11 A 433 LEU LEU SER ILE GLY GLY TRP THR TYR SER PRO ASN PHE SEQRES 12 A 433 ALA PRO ALA ALA SER THR ASP ALA GLY ARG LYS ASN PHE SEQRES 13 A 433 ALA LYS THR ALA VAL LYS LEU LEU GLN ASP LEU GLY PHE SEQRES 14 A 433 ASP GLY LEU ASP ILE ASP TRP GLU TYR PRO GLU ASN ASP SEQRES 15 A 433 GLN GLN ALA ASN ASP PHE VAL LEU LEU LEU LYS GLU VAL SEQRES 16 A 433 ARG THR ALA LEU ASP SER TYR SER ALA ALA ASN ALA GLY SEQRES 17 A 433 GLY GLN HIS PHE LEU LEU THR VAL ALA SER PRO ALA GLY SEQRES 18 A 433 PRO ASP LYS ILE LYS VAL LEU HIS LEU LYS ASP MET ASP SEQRES 19 A 433 GLN GLN LEU ASP PHE TRP ASN LEU MET ALA TYR ASP TYR SEQRES 20 A 433 ALA GLY SER PHE SER SER LEU SER GLY HIS GLN ALA ASN SEQRES 21 A 433 VAL TYR ASN ASP THR SER ASN PRO LEU SER THR PRO PHE SEQRES 22 A 433 ASN THR GLN THR ALA LEU ASP LEU TYR ARG ALA GLY GLY SEQRES 23 A 433 VAL PRO ALA ASN LYS ILE VAL LEU GLY MET PRO LEU TYR SEQRES 24 A 433 GLY ARG SER PHE ALA ASN THR ASP GLY PRO GLY LYS PRO SEQRES 25 A 433 TYR ASN GLY VAL GLY GLN GLY SER TRP GLU ASN GLY VAL SEQRES 26 A 433 TRP ASP TYR LYS ALA LEU PRO GLN ALA GLY ALA THR GLU SEQRES 27 A 433 HIS VAL LEU PRO ASP ILE MET ALA SER TYR SER TYR ASP SEQRES 28 A 433 ALA THR ASN LYS PHE LEU ILE SER TYR ASP ASN PRO GLN SEQRES 29 A 433 VAL ALA ASN LEU LYS SER GLY TYR ILE LYS SER LEU GLY SEQRES 30 A 433 LEU GLY GLY ALA MET TRP TRP ASP SER SER SER ASP LYS SEQRES 31 A 433 THR GLY SER ASP SER LEU ILE THR THR VAL VAL ASN ALA SEQRES 32 A 433 LEU GLY GLY THR GLY VAL PHE GLU GLN SER GLN ASN GLU SEQRES 33 A 433 LEU ASP TYR PRO VAL SER GLN TYR ASP ASN LEU ARG ASN SEQRES 34 A 433 GLY MET GLN THR SEQRES 1 B 433 MET ARG PHE ALA THR SER THR ILE VAL LYS VAL ALA LEU SEQRES 2 B 433 LEU LEU SER SER LEU CYS VAL ASP ALA ALA VAL MET TRP SEQRES 3 B 433 ASN ARG ASP THR SER SER THR ASP LEU GLU ALA ARG ALA SEQRES 4 B 433 SER SER GLY TYR ARG SER VAL VAL TYR PHE VAL ASN TRP SEQRES 5 B 433 ALA ILE TYR GLY ARG ASN HIS ASN PRO GLN ASP LEU PRO SEQRES 6 B 433 VAL GLU ARG LEU THR HIS VAL LEU TYR ALA PHE ALA ASN SEQRES 7 B 433 VAL ARG PRO GLU THR GLY GLU VAL TYR MET THR ASP SER SEQRES 8 B 433 TRP ALA ASP ILE GLU LYS HIS TYR PRO GLY ASP SER TRP SEQRES 9 B 433 SER ASP THR GLY ASN ASN VAL TYR GLY CYS ILE LYS GLN SEQRES 10 B 433 LEU TYR LEU LEU LYS LYS GLN ASN ARG ASN LEU LYS VAL SEQRES 11 B 433 LEU LEU SER ILE GLY GLY TRP THR TYR SER PRO ASN PHE SEQRES 12 B 433 ALA PRO ALA ALA SER THR ASP ALA GLY ARG LYS ASN PHE SEQRES 13 B 433 ALA LYS THR ALA VAL LYS LEU LEU GLN ASP LEU GLY PHE SEQRES 14 B 433 ASP GLY LEU ASP ILE ASP TRP GLU TYR PRO GLU ASN ASP SEQRES 15 B 433 GLN GLN ALA ASN ASP PHE VAL LEU LEU LEU LYS GLU VAL SEQRES 16 B 433 ARG THR ALA LEU ASP SER TYR SER ALA ALA ASN ALA GLY SEQRES 17 B 433 GLY GLN HIS PHE LEU LEU THR VAL ALA SER PRO ALA GLY SEQRES 18 B 433 PRO ASP LYS ILE LYS VAL LEU HIS LEU LYS ASP MET ASP SEQRES 19 B 433 GLN GLN LEU ASP PHE TRP ASN LEU MET ALA TYR ASP TYR SEQRES 20 B 433 ALA GLY SER PHE SER SER LEU SER GLY HIS GLN ALA ASN SEQRES 21 B 433 VAL TYR ASN ASP THR SER ASN PRO LEU SER THR PRO PHE SEQRES 22 B 433 ASN THR GLN THR ALA LEU ASP LEU TYR ARG ALA GLY GLY SEQRES 23 B 433 VAL PRO ALA ASN LYS ILE VAL LEU GLY MET PRO LEU TYR SEQRES 24 B 433 GLY ARG SER PHE ALA ASN THR ASP GLY PRO GLY LYS PRO SEQRES 25 B 433 TYR ASN GLY VAL GLY GLN GLY SER TRP GLU ASN GLY VAL SEQRES 26 B 433 TRP ASP TYR LYS ALA LEU PRO GLN ALA GLY ALA THR GLU SEQRES 27 B 433 HIS VAL LEU PRO ASP ILE MET ALA SER TYR SER TYR ASP SEQRES 28 B 433 ALA THR ASN LYS PHE LEU ILE SER TYR ASP ASN PRO GLN SEQRES 29 B 433 VAL ALA ASN LEU LYS SER GLY TYR ILE LYS SER LEU GLY SEQRES 30 B 433 LEU GLY GLY ALA MET TRP TRP ASP SER SER SER ASP LYS SEQRES 31 B 433 THR GLY SER ASP SER LEU ILE THR THR VAL VAL ASN ALA SEQRES 32 B 433 LEU GLY GLY THR GLY VAL PHE GLU GLN SER GLN ASN GLU SEQRES 33 B 433 LEU ASP TYR PRO VAL SER GLN TYR ASP ASN LEU ARG ASN SEQRES 34 B 433 GLY MET GLN THR SEQRES 1 C 5 VR0 MEA IAS IAS DAL SEQRES 1 D 5 VR0 MEA IAS IAS DAL MODRES 1W9V VR0 C 1434 ARG MODRES 1W9V MEA C 1435 PHE N-METHYLPHENYLALANINE MODRES 1W9V VR0 D 1434 ARG MODRES 1W9V MEA D 1435 PHE N-METHYLPHENYLALANINE HET VR0 C1434 15 HET MEA C1435 12 HET IAS C1436 8 HET IAS C1437 8 HET DAL C1438 5 HET VR0 D1434 15 HET MEA D1435 12 HET IAS D1436 8 HET IAS D1437 8 HET DAL D1438 5 HET SO4 A1438 5 HET SO4 A1439 5 HET SO4 A1440 5 HET SO4 B1437 5 HET SO4 B1438 5 HET SO4 B1439 5 HETNAM VR0 N~5~-[N-(METHYLCARBAMOYL)CARBAMIMIDOYL]-L-ORNITHINE HETNAM MEA N-METHYLPHENYLALANINE HETNAM IAS BETA-L-ASPARTIC ACID HETNAM DAL D-ALANINE HETNAM SO4 SULFATE ION HETSYN IAS L-ASPARTIC ACID FORMUL 3 VR0 2(C8 H17 N5 O3) FORMUL 3 MEA 2(C10 H13 N O2) FORMUL 3 IAS 4(C4 H7 N O4) FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 5 SO4 6(O4 S 2-) FORMUL 11 HOH *1080(H2 O) HELIX 1 1 TRP A 52 TYR A 55 5 4 HELIX 2 2 ASN A 60 LEU A 64 5 5 HELIX 3 3 PRO A 65 LEU A 69 5 5 HELIX 4 4 ASP A 90 GLU A 96 1 7 HELIX 5 5 TYR A 112 ASN A 125 1 14 HELIX 6 6 TYR A 139 PRO A 141 5 3 HELIX 7 7 ASN A 142 SER A 148 1 7 HELIX 8 8 THR A 149 GLY A 168 1 20 HELIX 9 9 ASN A 181 ALA A 207 1 27 HELIX 10 10 GLY A 221 LEU A 228 1 8 HELIX 11 11 HIS A 229 GLN A 235 1 7 HELIX 12 12 ASN A 267 THR A 271 5 5 HELIX 13 13 ASN A 274 GLY A 285 1 12 HELIX 14 14 PRO A 288 ASN A 290 5 3 HELIX 15 15 LYS A 329 LEU A 331 5 3 HELIX 16 16 PRO A 342 MET A 345 5 4 HELIX 17 17 ASN A 362 GLY A 377 1 16 HELIX 18 18 ASP A 385 ASP A 389 5 5 HELIX 19 19 THR A 391 ASP A 394 5 4 HELIX 20 20 SER A 395 GLY A 405 1 11 HELIX 21 21 GLY A 406 VAL A 409 5 4 HELIX 22 22 TYR A 424 ASN A 429 1 6 HELIX 23 23 TRP B 52 TYR B 55 5 4 HELIX 24 24 ASN B 60 LEU B 64 5 5 HELIX 25 25 PRO B 65 LEU B 69 5 5 HELIX 26 26 ASP B 90 ILE B 95 1 6 HELIX 27 27 TYR B 112 ASN B 125 1 14 HELIX 28 28 TYR B 139 PRO B 141 5 3 HELIX 29 29 ASN B 142 SER B 148 1 7 HELIX 30 30 THR B 149 GLY B 168 1 20 HELIX 31 31 ASN B 181 ALA B 207 1 27 HELIX 32 32 GLY B 221 LYS B 226 1 6 HELIX 33 33 HIS B 229 LEU B 237 1 9 HELIX 34 34 ASN B 267 THR B 271 5 5 HELIX 35 35 ASN B 274 GLY B 285 1 12 HELIX 36 36 PRO B 288 ASN B 290 5 3 HELIX 37 37 LYS B 329 LEU B 331 5 3 HELIX 38 38 PRO B 342 MET B 345 5 4 HELIX 39 39 ASN B 362 GLY B 377 1 16 HELIX 40 40 ASP B 385 ASP B 389 5 5 HELIX 41 41 THR B 391 ASP B 394 5 4 HELIX 42 42 SER B 395 GLY B 405 1 11 HELIX 43 43 GLY B 406 VAL B 409 5 4 HELIX 44 44 TYR B 424 ASN B 429 1 6 SHEET 1 AA11 ARG A 44 VAL A 50 0 SHEET 2 AA11 GLY A 380 TRP A 384 1 O ALA A 381 N VAL A 46 SHEET 3 AA11 ILE A 292 PRO A 297 1 O LEU A 294 N MET A 382 SHEET 4 AA11 PHE A 239 LEU A 242 1 O TRP A 240 N VAL A 293 SHEET 5 AA11 LEU A 213 SER A 218 1 O VAL A 216 N ASN A 241 SHEET 6 AA11 GLY A 171 ASP A 175 1 O LEU A 172 N THR A 215 SHEET 7 AA11 LYS A 129 GLY A 135 1 O LEU A 132 N ASP A 173 SHEET 8 AA11 HIS A 71 VAL A 79 1 O VAL A 72 N LEU A 131 SHEET 9 AA11 ARG A 44 VAL A 50 1 O VAL A 47 N LEU A 73 SHEET 10 AA11 GLY A 380 TRP A 384 1 O ALA A 381 N VAL A 46 SHEET 11 AA11 ARG A 44 VAL A 50 1 O ARG A 44 N ALA A 381 SHEET 1 AB 5 VAL A 325 ASP A 327 0 SHEET 2 AB 5 TYR A 299 PHE A 303 -1 O GLY A 300 N TRP A 326 SHEET 3 AB 5 PHE A 356 SER A 359 -1 O LEU A 357 N PHE A 303 SHEET 4 AB 5 ALA A 346 ASP A 351 -1 O SER A 349 N ILE A 358 SHEET 5 AB 5 THR A 337 LEU A 341 -1 O THR A 337 N TYR A 350 SHEET 1 BA10 ARG B 44 VAL B 50 0 SHEET 2 BA10 GLY B 380 TRP B 384 1 O ALA B 381 N VAL B 46 SHEET 3 BA10 ILE B 292 PRO B 297 1 O LEU B 294 N MET B 382 SHEET 4 BA10 PHE B 239 LEU B 242 1 O TRP B 240 N VAL B 293 SHEET 5 BA10 LEU B 213 SER B 218 1 O VAL B 216 N ASN B 241 SHEET 6 BA10 GLY B 171 ASP B 175 1 O LEU B 172 N THR B 215 SHEET 7 BA10 LYS B 129 GLY B 135 1 O LEU B 132 N ASP B 173 SHEET 8 BA10 HIS B 71 VAL B 79 1 O VAL B 72 N LEU B 131 SHEET 9 BA10 ARG B 44 VAL B 50 1 O VAL B 47 N LEU B 73 SHEET 10 BA10 ARG B 44 VAL B 50 1 N VAL B 50 O TYR B 48 SHEET 1 BB 5 VAL B 325 ASP B 327 0 SHEET 2 BB 5 TYR B 299 PHE B 303 -1 O GLY B 300 N TRP B 326 SHEET 3 BB 5 PHE B 356 SER B 359 -1 O LEU B 357 N PHE B 303 SHEET 4 BB 5 ALA B 346 ASP B 351 -1 O SER B 349 N ILE B 358 SHEET 5 BB 5 THR B 337 LEU B 341 -1 O THR B 337 N TYR B 350 LINK C VR0 C1434 N MEA C1435 1555 1555 1.33 LINK N VR0 C1434 C DAL C1438 1555 1555 1.33 LINK C MEA C1435 N IAS C1436 1555 1555 1.33 LINK CG IAS C1436 N IAS C1437 1555 1555 1.33 LINK CG IAS C1437 N DAL C1438 1555 1555 1.33 LINK C VR0 D1434 N MEA D1435 1555 1555 1.33 LINK N VR0 D1434 C DAL D1438 1555 1555 1.33 LINK C MEA D1435 N IAS D1436 1555 1555 1.33 LINK CG IAS D1436 N IAS D1437 1555 1555 1.33 LINK CG IAS D1437 N DAL D1438 1555 1555 1.33 CISPEP 1 ALA A 75 PHE A 76 0 -3.20 CISPEP 2 GLU A 177 TYR A 178 0 -1.49 CISPEP 3 LEU A 331 PRO A 332 0 -0.13 CISPEP 4 TRP A 384 ASP A 385 0 -3.73 CISPEP 5 ALA B 75 PHE B 76 0 -2.51 CISPEP 6 GLU B 177 TYR B 178 0 -1.90 CISPEP 7 LEU B 331 PRO B 332 0 -0.30 CISPEP 8 TRP B 384 ASP B 385 0 -5.42 CISPEP 9 VR0 C 1434 MEA C 1435 0 -0.37 CISPEP 10 VR0 D 1434 MEA D 1435 0 -0.36 SITE 1 AC1 6 HIS A 229 LEU A 230 LYS A 231 ASP A 232 SITE 2 AC1 6 HOH A2325 HOH A2569 SITE 1 AC2 6 GLY A 406 THR A 407 HOH A2524 HOH A2525 SITE 2 AC2 6 HOH A2571 HOH A2572 SITE 1 AC3 6 HOH A2129 HOH A2573 HOH A2574 HOH A2575 SITE 2 AC3 6 ARG B 283 ALA B 289 SITE 1 AC4 4 THR B 149 ASP B 150 HOH B2503 HOH B2504 SITE 1 AC5 7 HIS B 229 LEU B 230 LYS B 231 ASP B 232 SITE 2 AC5 7 HOH B2264 HOH B2325 HOH B2505 SITE 1 AC6 2 ASN B 181 ASP B 182 SITE 1 AC7 20 TYR A 48 TRP A 137 THR A 138 ASP A 175 SITE 2 AC7 20 GLU A 177 TYR A 178 MET A 243 TYR A 245 SITE 3 AC7 20 ASP A 246 PHE A 251 ARG A 301 GLU A 322 SITE 4 AC7 20 TRP A 384 HOH C2561 HOH C2562 HOH C2563 SITE 5 AC7 20 HOH C2564 HOH C2565 HOH C2566 HOH C2567 SITE 1 AC8 26 HOH A2452 TYR B 48 TRP B 137 THR B 138 SITE 2 AC8 26 ASP B 175 GLU B 177 TYR B 178 MET B 243 SITE 3 AC8 26 TYR B 245 ASP B 246 PHE B 251 ARG B 301 SITE 4 AC8 26 TRP B 384 HOH B2359 HOH D2490 HOH D2491 SITE 5 AC8 26 HOH D2493 HOH D2494 HOH D2495 HOH D2496 SITE 6 AC8 26 HOH D2497 HOH D2498 HOH D2499 HOH D2500 SITE 7 AC8 26 HOH D2501 HOH D2502 CRYST1 117.704 117.704 99.783 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008496 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008496 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010022 0.00000